GLR-1027

N/A

Report date: 2023/02/22 17:17:26

Base Information

Drug NameGLR-1027
Drug Alias NameAnti-IL-12/23p40 monoclonal antibody优特克诺Anti-interleukin-12 p40 monoclonal antibody人源抗白介素12单克隆抗体(CNTO 1275)注射剂Ustekinumabum +[11] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar
Mechanisms of ActionInterleukin-12 inhibitorsInterleukin-23 inhibitors
TargetsInterleukin-12Interleukin-23
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG